Shaping the Future of AI Medical Devices: A Symposium on the Regulation of AI in Health Care and its Policy Implications
With more than 690 FDA-approved artificial intelligence (AI) medical devices available, the use of AI in health care presents unique regulatory challenges that require careful consideration. This symposium, co-hosted by the Johns Hopkins Carey Business School and Johns Hopkins School of Medicine, will explore lessons from this relatively short regulatory history.